AstraZeneca Offers Online Enrollment and Additional Improvements to Patient Assistance Program
WILMINGTON, Del., Jan. 13 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) announced today that enrollment and re-enrollment for two of its prescription savings programs is available online for the first time at www.azandme.com.
In addition, online self-service options are available for both programs, which enable health care providers, advocates and patients to order and monitor the shipping of refills and check the status of their enrollment online at www.azandme.com. AstraZeneca is the first pharmaceutical company to provide these self-service options directly to patients.
"We are using more tools to help patients get the medicines and information they need in an efficient and timely way," said Jennifer McGovern, AstraZeneca Director of Patient Assistance Programs. "We hope to be able to better serve patients and the people who support them by continually making program enhancements."
For over 30 years, AstraZeneca has offered patient assistance, because the company knows that medicines can only make a difference if patients can access them. Web-based improvements are another way that AstraZeneca is strengthening its commitment to patient health.
To learn more about the program, get a list of available medicines, or to see if you qualify for an AZ&Me™ Prescription Savings program, please call 1-800-AZandMe (292-6363) or visit www.azandme.com. Assistance specialists are available Monday through Friday between 8 AM and 6 PM EST.
For those who prefer completing a hard-copy application, the AZ&Me™ Prescription Savings program for people without insurance and for people with Medicare Part D now also offers one streamlined application for both programs. The application is available in English and Spanish at www.azandme.com or by calling 1-800-AZandMe (292-6363).
Prescription savings programs are available regardless of which medications doctors prescribe. To find out more about the more than 475 savings programs covering 2,500 medications, please visit www.pparx.org or call 1-888-4PPA-NOW (1-888-477-2669).
NOTES TO EDITORS:
AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.
For more information about AstraZeneca in the US or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com.
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.